Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
“The future of breast cancer therapy is tied to the idea of individualizing treatment for each patient,” says Sara Tolaney, MD, MPH.
Venclexta alone or in combination with Rituxan improved progression-free survival in patients with chronic lymphocytic leukemia.
A look back at some of the major news stories we covered this year.
The goal of developing this type of test “is to safely prevent unnecessary surgeries,” said lead investigator Yuri Nikiforov, MD, PhD.
In this state, Black women die of this preventable cancer at nearly double the rate of white women.
ORR, PFS, TTP…we help you sort out what they mean.
Lisa Vento Nielsen, MBA, PMP, is founder of the Balance After Cancer Foundation and creator of the SuperMom—Breast Cancer Eradicator blog.
Yolanda Brunson-Sarrabo was diagnosed with smoldering myeloma in 2008.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.